483 GlaxoSmithKline Apr 2016

483 GlaxoSmithKline Apr 2016

Sonya Edmonds FDA, Tamara Henderson FDA, Rebecca Rodriguez FDA$119.00 - Available Now

FDA investigators audited the GlaxoSmithKline - Zebulon, NC, United States facility and issued inspectional observations (via FDA 483) on 21 Apr 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 21 Apr 2016
  • Location: Zebulon, United States
  • FEI: 1033964
Add To Cart